New Cardiovascular Risk Assessment Techniques for Primary Prevention: JACC Review Topic of the Week

Area of Science:

• Cardiovascular disease risk prediction
• Preventive cardiology
• Biomarkers in atherosclerosis

Background:

• Traditional risk factor models exhibit limitations in accurately assessing cardiovascular disease (CVD) risk, particularly in younger populations and individuals categorized as intermediate risk.
• A significant number of individuals fall into the intermediate-risk category, necessitating more precise preventive strategies.
• Existing risk assessment tools may not fully capture individual risk profiles, leading to suboptimal clinical decisions.

Purpose of the Study:

• To evaluate the potential of emerging personalized risk prediction tools to enhance cardiovascular risk assessment.
• To explore the benefits of a multidimensional approach for precise risk stratification.
• To identify opportunities for early intervention in coronary atherosclerosis development.

Main Methods:

• Review of current risk factor-based models and their limitations.
• Assessment of emerging personalized risk prediction tools, including coronary artery calcium scoring, polygenic risk scores, and metabolic risk scores.
• Discussion of the potential impact of multidimensional risk prediction on clinical practice and patient outcomes.

Main Results:

• Risk factor-based models demonstrate suboptimal accuracy in specific populations, such as younger individuals.
• Personalized risk prediction tools show promise in improving risk stratification for intermediate-risk individuals.
• Clinical trial outcome data is crucial for validating the effectiveness of these advanced tools.

Conclusions:

• A multidimensional approach to risk prediction offers the potential for precise cardiovascular risk assessment.
• Enhanced risk prediction can facilitate targeted prevention, optimizing benefits while minimizing costs and risks.
• Early identification of high-risk individuals can enable interventions to prevent future clinical events and slow atherosclerosis progression.